Hematological Indices and Sympathetic Block Response in Neuropathic Pain
Recruiting
Observational Study
Neuropathic Pain
Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Ankara City Hospital Bilkent · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective observational study aims to evaluate the relationship between hematological inflammatory indices and clinical treatment response in patients with neuropathic pain undergoing sympathetic nerve block procedures as part of routine clinical care. Hematological parameters including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (M…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Diagnosis of neuropathic pain based on clinical evaluation
* DN4 and/or LANSS scores compatible with neuropathic pain
* Undergoing sympathetic nerve block as part of routine clinical treatment
* Availability of pre-treatment and follow-up hemogram parameters
* …
Contacts